The Centers for Medicare & Medicaid Services (CMS) has finalized the Contract Year (CY) 2027 Medicare Advantage and Part D Final Rule, adjusting several policies that affect how agents operate.
After several years in which new rules often meant more documentation and second-guessing, the 2027 Final Rule moves in a different direction. CMS kept core beneficiary protections in place while rolling back requirements that created workflow barriers for agents.
While not a major rewrite of Medicare marketing rules, it does simplify how your business moves from initial interest to enrollment.
To understand the 2027 rule, it helps to start with what CMS appears to be prioritizing. First, the agency is moving away from administrative rules that create delays without delivering measurable benefit. Second, CMS is trying to preserve consumer protections without defaulting to one‑size‑fits‑all restrictions. Finally, the rule aims to stabilize Medicare Advantage and Part D in CY 2027, particularly as plans, agents, and beneficiaries adjust to recent changes in pricing, Star Ratings, and drug coverage.
One of the most significant changes for agents is the elimination of the long‑standing 48‑hour Scope of Appointment (SOA) waiting period. Previously, even when a beneficiary was ready to move forward, agents were required to wait two full days after collecting an SOA before holding a one‑on‑one plan discussion. In reality, that delay often meant lost momentum, missed follow‑ups, and/or frustration on both sides.
In CY 2027, CMS has removed that waiting requirement. Agents may now collect an SOA and proceed with an appointment the same day, provided all SOA requirements are met and documented appropriately. The SOA itself has not changed; the 48-hour time frame has been removed.
For many agents, this restores their ability to assist beneficiaries when they are actively asking for help, rather than telling them to wait because the rules require it.
This trend continues in CMS’s approach to events for CY 2027. The agency has removed the mandatory 12‑hour buffer between educational and marketing events held at the same location. Agents may move from education to marketing or enrollment in the same setting, provided attendees are clearly notified of the change and given the chance to leave.
CMS also restored the ability for agents to make SOA forms available and collect them at educational events, provided no plan‑specific marketing occurs during the educational portion.
By clarifying that SOA collection is not a marketing activity on its own, CMS made it easier for educational conversations to lead into compliant follow‑up.
The 2027 rule also revises Third‑Party Marketing Organization (TPMO) disclaimer requirements to allow for more natural call openings.
Instead of focusing on whether a disclaimer is delivered within an arbitrary number of seconds, CMS now requires it to be delivered before any discussion of plan benefits. This gives agents room to open a conversation professionally before shifting into compliance language, while still ensuring disclosures happen before benefit discussions begin.
CMS also removed references to State Health Insurance Assistance Programs (SHIP) from the disclaimer language, leaving Medicare.gov and 1‑800‑MEDICARE as the standard references.
Beyond marketing, the Final Rule includes a notable reset of the Star Ratings system. CMS finalized its decision not to implement the Excellent Health Outcomes for All reward (previously called the Health Equity Index) for the 2027 Contract Year. Instead, CMS will continue its existing approach, which rewards plans for performing well across their entire membership.
CMS removed 11 administrative Star Ratings measures that offered little plan‑to‑plan distinction, allowing more focus on outcomes and member experience. The addition of a new depression screening and follow‑up measure reinforces a continued focus on behavioral health.
The 2027 Final Rule locked in Part D changes that came from the Inflation Reduction Act. These include:
For agents, this means simpler, more consistent drug coverage conversations. Discussions become more straightforward when the rules are no longer described as transitional or temporary.
CMS declined to move forward with several proposals that would have added complexity, including a new special enrollment period tied to provider terminations. By holding back on those changes, the agency avoided introducing additional mid‑year disruption for beneficiaries.
The CY 2027 CMS Final Rule simplifies requirements that added complexity without improving outcomes. While the path from initial interest to enrollment is more direct in CY 2027, expectations around compliance, documentation, and ethical conduct remain the same.
For established agents, these updates mainly affect day‑to‑day operations. Reviewing and updating scripts, seminar formats, SOA workflows, and call openings ahead of AEP can help ensure a smoother and more consistent enrollment process.
Overall, the 2027 rule makes it easier to operate day to day, while keeping compliance and beneficiary protections in place.
CMS Final Rule Flyer available here.